SECsense Logo

Edwards Lifesciences Corporation 8-K Filing Report: Key Developments Unveiled

$EW
Form 8-K
Filed on: 2025-02-11
Source
Edwards Lifesciences Corporation 8-K Filing Report: Key Developments Unveiled

Based on the provided section of the financial report, here are the extracted key pieces of information:

  1. Entity Information:
  • Name: Edwards Lifesciences Corporation
  • CIK: 0001099800
  • Address: One Edwards Way, Irvine, CA 92614
  • Phone Number: 949-250-2500
  • Stock Exchange: NYSE
  • Ticker Symbol: EW
  • Common Stock: Par value of $1.00 per share
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: February 11, 2025
  1. Period of Reporting:
  • Start Date: February 11, 2025
  • End Date: February 11, 2025
  1. SEC Compliance:
  • SEC Filing Identifier: 1-15525
  • Tax ID (EIN): 36-4316614

Insights:

  • The report is an 8-K filing, which typically indicates that the company is reporting significant events that shareholders should know about, such as acquisitions, changes in management, or other major developments.
  • The filing date is the same as the reporting period, which suggests this may be a current report reflecting an immediate event or development rather than a quarterly or annual report.
  • As a publicly traded company, Edwards Lifesciences Corporation is subject to SEC regulations and must disclose material information to maintain transparency with investors.

These insights can help investors and analysts understand the context and potential implications of the filing.